NCT05167487View on ClinicalTrials.gov

Pathological Response After Neoadjuvant Treatment on NSCLC

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

April 1, 2025

Study Completion Date

December 1, 2025

Conditions
Stage IIIA Non-small Cell Lung Cancer
Interventions
DRUG

Cisplatin

Route of administration: Intravenous infusion. Neoadjuvant chemotherapy is often given 2 to 4 months before surgery.

DRUG

Carboplatin

Route of administration: Intravenous infusion. Neoadjuvant chemotherapy is often given 2 to 4 months before surgery.

Trial Locations (17)

15006

RECRUITING

Hospital Universitario De A Coruna, A Coruña

28040

RECRUITING

Hospital Clínico San Carlos, Madrid

RECRUITING

Hospital Universitario Fundación Jiménez Díaz, Madrid

28041

RECRUITING

Hospital 12 De Octubre, Madrid

28046

RECRUITING

Hospital Universitario la Paz, Madrid

28222

RECRUITING

Hospital Universitario Puerta de Hierro, Majadahonda

29010

RECRUITING

Hospital Universitario Regional de Málaga, Málaga

35010

RECRUITING

Hospital Dr. Negrín, Las Palmas de Gran Canaria

35016

RECRUITING

Hospital Universitario Insular de Gran canaria, Las Palmas de Gran Canaria

36036

RECRUITING

Complejo Hospitalario Universitario de Vigo, Vigo

46026

RECRUITING

Hospital Universitario La Fe, Valencia

48903

RECRUITING

Hospital Universitario Cruces, Barakaldo

03010

RECRUITING

Hospital General Universitario de Alicante, Alicante

08916

RECRUITING

ICO Badalona, Hospital Germans Trias i Pujol, Badalona

08035

RECRUITING

Hospital Vall d'Hebron, Barcelona

08041

RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

08908

RECRUITING

ICO Hospitalet, L'Hospitalet de Llobregat

All Listed Sponsors
lead

Fundación GECP

OTHER